Your browser doesn't support javascript.
loading
Research progress of ALCAM in gynecological malignant tumors / 实用肿瘤学杂志
Practical Oncology Journal ; (6): 381-384, 2017.
Article em Zh | WPRIM | ID: wpr-611373
Biblioteca responsável: WPRO
ABSTRACT
Activated leukocyte cell adhesion(ALCAM),also known as CD166/MEMD,is a transmembrane glycoprotein,which belongs to one of the members of the immunoglobulin superfamily and is one of cell adhesion molecules.In vivo,ALCAM is divided into three subtypes including membrane ALCAM,cytoplasmic ALCAM and soluble ALCAM,which mediate a variety of pathophysiological processes involved in the body by regulating cell-to-cell tropism or heterophonic adhesion.The abnormal expression of ALCAM is closely related to the invasion and metastasis of various tumor cells,and has a certain effect on the sensitivity of radiotherapy and chemotherapy.The article reviews the latest advances in ALCAM of gynecological malignancies.
Palavras-chave
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: Practical Oncology Journal Ano de publicação: 2017 Tipo de documento: Article
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: Practical Oncology Journal Ano de publicação: 2017 Tipo de documento: Article